Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Dr. Lal Pathlabs Limited Board/Management Information 2020

Feb 3, 2020

61783_rns_2020-02-03_0ee39659-2c72-453a-af9a-95e347bb126c.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

February 3, 2020

National Stock Exchange of India Limited Exchange Plaza, Plot No. C/1, G Block, Sandra Kurla Complex Sandra (E) Mumbai - 400 051

BSE Limited Corporate Relationship Department Phiroze Jeejeebhoy Towers Dalal Street Mumbai- 400001

Sub: Intimation of Re-designation & Appointment of Directors and KMP.

Ref: Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI LODR Regulations")

Dear Sir/Madam,

Please take note that, based on recommendations of Nomination and Remuneration Committee, the Board of Directors in their meeting held today i.e February 3, 2020, approved the following matters:

    1. Re-designating (Hony) Brig. Dr. Arvind Lal by appointing him as Executive Chairman and Whole Time Director for a period of two (2) years, commencing from April 1, 2020 from his present designation of Chairman and Managing Director of the Company.
    1. Re-designating Dr. Om Prakash Manchanda by appointing him as Managing Director for a period of five (5) years, commencing from April 1, 2020 from his present designation of CEO & Whole-Time Director of the Company.
    1. Re-appointment of Dr. Vandana Lal as Whole-Time Director of the Company for a period of five (5) years, commencing from April 1, 2020.
    1. Re-designating Mr. Bharath Uppiliappan by appointing him as Chief Executive Officer (CEO) and Key Managerial Personnel (KMP), commencing from April 1, 2020 from his present designation of CEO (India Business) of the Company.

The Re-designation/Re-appoi_ntment of (Hony) Brig. Dr. Arvind Lal, Dr. Om Prakash Manchanda and Dr. Vandana Lal, is subject to approval of Shareholders of the Company.

Please also take note that (Hony) Brig. Dr. Arvind Lal, Dr. Om Prakash Manchanda and Dr. Vandana Lal are not debarred from holding the office of Director by virtue of any order of Securities and Exchange Board of India or any other such Authority.

Details as required under Regulation 30 of the SEBI LODR Regulations are a_ttached herewith as an Annexure A.

Thanking You, Yours Faithfully,

Rajat Kalra Company Secretary & Legal Head

Encl: As above

Annexure-A

$\frac{1}{2}$

Particulars (Hony) Brig. Dr. Arvind Lal Dr. Om Prakash Manchanda Dr. Vandana Lal Mr. Bharath Uppiliappan
forReason Re-designated as Executive Re-designated as Managing Director of Re-appointment as Whole Time Re-designated as CEO &
Change Chairman and Whole Time the Company. Director of the Company. KMP of the Company.
Director of the Company.
re-appointment of Dr.The The re-designation of Mr.
ofDate The re-designation of (Hony) The re-designation of Dr. Om Prakash Vandana Lal as Whole-Time Bharath U as CEO & KMP
Appointment & Dr.Arvind LalasBrig. Manchanda as Managing Director shall shall be effective from April 1,
ofterm ChairmanExecutiveand be effective from April 1, 2020 for a Director shall be effective from
Appointment Whole Time Director shall be period of Five (5) years and is subject to April 1, 2020 for a period of Five 2020 and the terms of
effective from April 1, 2020 for the approval of shareholders of the (5) years and is subject to the beappointmentshall
a period of two (2) years and is Company. The office of Dr. Om shall be approval of shareholders of the governed by the Company's
subject to the approval of liable to retire by rotation. Company. The office of Dr. policy.
shareholders of the Company. Vandana Lal shall be liable to
The office of (Hony) Brig. Dr. retire by rotation.
Arvind Lal shall not be liable to
retire by rotation.
Brief Profile (Hony) Brig. Dr. Arvind Lal is a Dr. Om holds a bachelor's degree in Dr. Vandana Lal is a promoter of Mr. Bharath Uppiliappan
promoter of Dr. Lal PathLabs veterinary science and animal husbandry Dr. Lal PathLabs, she holds a has been associated with
and holds a bachelor's degree from The Haryana Agricultural University, bachelor's degree in medicine sinceCompanythe
in medicine and surgery from Hisar and a postgraduate diploma in and a bachelor's degree in October 2016 in varying
the University of Poona and a management (agriculture) from the Indian surgery from the University of capacities.
diploma in clinical pathology Institute of Management, Ahmedabad Delhi and a doctorate degree in pathLabo
ForcestheArmedfrom ("IIMA"). medicine (pathology) from the $\sigma$
$\overline{a}$miteio.$\bullet$

$\ddot{\phantom{0}}$

$\sim 20$ $\sim$

$\mathcal{X}$

Medical College, Pune. He After graduating from the IIMA in June University of Delhi. She has over He is an Electrical and
has been conferred by the 1990, he was selected as a management 33 years of experience in the Electronics Engineer from
President of India an Honorary trainee for Lipton India Limited now field of pathology. NIT Trichy and has a
Brigadier's rank in the Armed amalgamated into Hindustan Unilever PGDM from SP Jain
Forces Medical Services and Limited ("HUL"}, under the management Dr. Vandana Lal is also trained in Institute of Management
also the Padma Shri award. trainee scheme of Unilever Group of I Quality Assurance and I & Research, Mumbai. In
Companies in India. spearheadsthequality his 25 year career so far,
He has over 43 years of implementation process in all the he has been focused on
experience in the field of He has worked with HUL in various laboratories of Dr Lal PathLabs . buildingbrandsand
Pathology and is recognized positions suchasAreaManager, She is the head of Clinical businesses across start
as a pioneer in bringing Innovation Manager-Beverages, Research Services being the up, growthand
laboratory services in India at BusinessManager-LooseTea, Chief Technical Officer since turnaround phases with
par with the western world. Brookfields and Senior Product Manager. 2007, playing a pivotal role in industry leading
Under his expert guidance and In HUL as a Senior Product Manager - conception,planning, companiesviz.FMCG
leadership, Dr. Lal Innovation,hespearheaded the construction,execution& (Hindustan. Unilever Ltd},
PathLabs has become one of execution of Tea Based Beverage operationalizing the Clinical trials Retailing (Bharti Walmart
the most reputed laboratories development project under the brand division. She also heads the - BhartiRetailLtd)
in Asia, name of Lipton Tiger. This innovation Research & Development wing Telecom(BhartiAirtel
went on to win many awards viz., Unilever I of Dr Lal PathLabs by monitoring Ltd.)inmultiple
He brought International I Central Asia and Mi_ddle East ("CAME") development of new tests and categorieslike· Foods,
recognitiontothe Indian I Best Marketable Idea of the Year Award I methods. Apparel, Home, Personal
Healthcare Industry in the in 1997, CAME Innovation Award for Best Care,General
form of accreditation from the I Proven Initiative of the Year in 1998 and I She is the Executive Director of I Merchandise and telecom
College ofAmerican Unilever Foods Innovation Award in Dr. Lal PathLabs since 1995. across both "India and
Pathologists (CAP -USA). Beverages Category in the year 1999. Herjobprofileincludes Bharat"
expansion of activities of the
laboratory with assistance in ' � _,,((]\
-.J--;·

, <.) ·,

revolutionizedDr.Lalhas Prior to joining Dr. Lal PathLabs, he has planning and execution of new
medicinelaboratoryby also worked with Monsanto India Limited projects for the company; overall
introducingmaximumthe as their National Marketing Manager and charge of all the technical
numberoftests,new Nationalthereafter astheirSales departments ensuring accuracy,
ICTinstrumentsand Manager. In January 2003 he joined quality assurance, quality control
(Information, Communications, Ranbaxy Laboratory Limited in their & compliance to standards laid
Technology) systems. Global Consumer Healthcare Division down by the accreditation bodies
and worked initially as General Manager like CAP, NABL & ISO.
- Marketing, Consumer Healthcare (India)
and then General Manager - International
& Innovation before joining Dr. Lal
PathLabs in October 2005.
Disclosureof (Hony) Brig. Dr. Arvind Lal is Dr. Om is not related to any Director of the Dr. Vandana Lal is related to Mr. Bharath Uppiliappan is not
relationships related to Dr. Vandana Lal Company. (Hony) Brig. Dr. Arvind Lal related to any Director of the
between (Wife) and Dr. Archana Lal (Husband) and Dr. Archana Lal Company.
Directors Erdmann (Daughter) Erdmann (Daughter)

$\gamma_E$

$\mathcal{G}$

PathLabs $\Lambda\phi^{\prime}$ NEI $\overline{q}$

$\alpha$